← Leaderboards
Roza Insafetdinovna Nurieva
University Of Tx Md Anderson Can Ctr
$10,025,772
Attributed
$10,025,772
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,025,772 · 11
By mechanism
R01$8,799,296 · 5
R03$486,476 · 4
R21$440,000 · 1
R56$300,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Lanlan Shen$6,924,000
- Jae-Il Park$5,811,462
- Roberto Adachi$2,946,224
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsT-LymphocyteIn VivoCell PhysiologyReagentIn VitroInsightGenesCd4 Positive T LymphocytesRegulationUbiquitin-Protein LigaseGenerationsKnockout MiceMolecularResponseCytokinePropertyPreventAutoimmune DiseasesAutoimmunityPeripheralPreventionInflammationPathogenesis
Grant awards (26)
Role of GRAIL in B cell tolerance and B-cell mediated inflammation$2,630,572
R01 · FY2025 · AI · contact PI
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors$370,575
R01 · FY2025 · CA · contact PI
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors$352,047
R01 · FY2024 · CA · contact PI
Role of Grail in colon inflammation and tumorigenesis$163,500
R03 · FY2024 · CA · contact PI
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors$370,575
R01 · FY2023 · CA · contact PI
Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance$400,000
R01 · FY2022 · HL · contact PI
Role of Cul4A in Governing Th2-Type Tolerance$400,000
R01 · FY2021 · HL · contact PI
Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance$400,000
R01 · FY2021 · HL · contact PI
Role of Cul4A in Governing Th2-Type Tolerance$400,000
R01 · FY2020 · HL · contact PI
Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance$400,000
R01 · FY2020 · HL · contact PI
Role of Cul4A in Governing Th2-Type Tolerance$400,000
R01 · FY2019 · HL · contact PI
Role of E3 Ubiquitin ligase RNF133 in T cell function and tolerance$400,000
R01 · FY2019 · HL · contact PI
Function of T follicular helper cells in anti-tumor immunity$2,976
R03 · FY2019 · CA · contact PI
Role of Cul4A in Governing Th2-Type Tolerance$400,000
R01 · FY2018 · HL · contact PI
Grail-targeting breaks the immune tolerance to melanoma$80,000
R03 · FY2018 · CA · contact PI
Role of Cul4A in Th2 tolerance and airway inflammation$300,000
R56 · FY2017 · AI · contact PI
STAT1: New regulator of inflammatory Th17 and Th2 cells$200,000
R21 · FY2017 · AI · contact PI
Grail-targeting breaks the immune tolerance to melanoma$80,000
R03 · FY2017 · CA · contact PI
STAT1: New regulator of inflammatory Th17 and Th2 cells$240,000
R21 · FY2016 · AI · contact PI
Role of Grail in maintaining humoral immune tolerance$80,000
R03 · FY2016 · AI · contact PI
Role of Grail in maintaining humoral immune tolerance$80,000
R03 · FY2015 · AI · contact PI
Regulation of T cell activation and tolerance by Grail$354,699
R01 · FY2013 · AI · contact PI
Regulation of T cell activation and tolerance by Grail$377,339
R01 · FY2012 · AI · contact PI
Regulation of T cell activation and tolerance by Grail$377,339
R01 · FY2011 · AI · contact PI
Regulation of T cell activation and tolerance by Grail$381,150
R01 · FY2010 · AI · contact PI
Regulation of T cell activation and tolerance by Grail$385,000
R01 · FY2009 · AI · contact PI